Fogar P - Search Results

1

Common genetic variants associated with pancreatic adenocarcinoma may also modify risk of pancreatic neuroendocrine neoplasms.

Obazee O, Capurso G, Tavano F, Archibugi L, De Bonis A, Greenhalf W, Key T, Pasquali C, Milanetto AC, Hackert T, Fogar P, Liço V, Dervenis C, Lawlor RT, Landoni L, Gazouli M, Zambon CF, Funel N, Strobel O, Jamroziak K, Cantù C, Malecka-Panas E, Landi S, Neoptolemos JP, Basso D, Talar-Wojnarowska R, Rinzivillo M, Andriulli A, Canzian F, Campa D. Obazee O, et al. Among authors: fogar p. Carcinogenesis. 2018 Mar 8;39(3):360-367. doi: 10.1093/carcin/bgx150. Carcinogenesis. 2018. PMID: 29309705

2

Extra-hepatic cholestasis determines a reversible increase of glycoproteic tumour markers in benign and malignant diseases.

Basso D, Meggiato T, Fabris C, Plebani M, Fogar P, Panozzo MP, Del Favero G. Basso D, et al. Among authors: fogar p. Eur J Clin Invest. 1992 Dec;22(12):800-4. doi: 10.1111/j.1365-2362.1992.tb01449.x. Eur J Clin Invest. 1992. PMID: 1478251

3

Diabetes mellitus in pancreatic cancer follow-up.

Fogar P, Pasquali C, Basso D, Sperti C, Panozzo MP, Tessari G, D'Angeli F, Del Favero G, Plebani M. Fogar P, et al. Anticancer Res. 1994 Nov-Dec;14(6B):2827-30. Anticancer Res. 1994. PMID: 7532931 Clinical Trial.

4

Beta-cell function in pancreatic adenocarcinoma.

Basso D, Plebani M, Fogar P, Del Favero G, Briani G, Meggiato T, Panozzo MP, Ferrara C, D'Angeli F, Burlina A. Basso D, et al. Among authors: fogar p. Pancreas. 1994 May;9(3):332-5. doi: 10.1097/00006676-199405000-00008. Pancreas. 1994. PMID: 8022755

5

Tumor markers in the diagnosis, monitoring and therapy of pancreatic cancer: state of the art.

Plebani M, Basso D, Panozzo MP, Fogar P, Del Favero G, Naccarato R. Plebani M, et al. Among authors: fogar p. Int J Biol Markers. 1995 Oct-Dec;10(4):189-99. doi: 10.1177/172460089501000401. Int J Biol Markers. 1995. PMID: 8750644 Review.

6

Neural cell adhesion molecule (N-CAM) in gastrointestinal neoplasias.

Fogar P, Basso D, Pasquali C, De Paoli M, Sperti C, Roveroni G, Pedrazzoli S, Plebani M. Fogar P, et al. Anticancer Res. 1997 Mar-Apr;17(2B):1227-30. Anticancer Res. 1997. PMID: 9137477

7

Portal but not peripheral serum levels of interleukin 6 could interfere with glucose metabolism in patients with pancreatic cancer.

Fogar P, Basso D, Pasquali C, Piva MG, Brigato L, De Paoli M, Galeotti F, Corsini A, Plebani M. Fogar P, et al. Clin Chim Acta. 1998 Oct;277(2):181-9. doi: 10.1016/s0009-8981(98)00125-9. Clin Chim Acta. 1998. PMID: 9853701

8

ME-PCR for the identification of mutated K-ras in serum and bile of pancreatic cancer patients: an unsatisfactory technique for clinical applications.

Zambon C, Navaglia F, Basso D, Gallo N, Greco E, Piva MG, Fogar P, Pasquali C, Pedrazzoli S, Plebani M. Zambon C, et al. Among authors: fogar p. Clin Chim Acta. 2000 Dec;302(1-2):35-48. doi: 10.1016/s0009-8981(00)00351-x. Clin Chim Acta. 2000. PMID: 11074062

9

CEA mRNA identification in peripheral blood is feasible for colorectal, but not for gastric or pancreatic cancer staging.

Piva MG, Navaglia F, Basso D, Fogar P, Roveroni G, Gallo N, Zambon CF, Pedrazzoli S, Plebani M. Piva MG, et al. Among authors: fogar p. Oncology. 2000 Nov;59(4):323-8. doi: 10.1159/000012190. Oncology. 2000. PMID: 11096345

10

Putative pancreatic cancer-associated diabetogenic factor: 2030 MW peptide.

Basso D, Valerio A, Seraglia R, Mazza S, Piva MG, Greco E, Fogar P, Gallo N, Pedrazzoli S, Tiengo A, Plebani M. Basso D, et al. Among authors: fogar p. Pancreas. 2002 Jan;24(1):8-14. doi: 10.1097/00006676-200201000-00002. Pancreas. 2002. PMID: 11741177

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

107 results

Search Page